SCHEMBL7378474

SCHEMBL7378474

[CH2]c1cccc(-c2cc(N(CC)CC)on2)c1

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
F2R P25116 11/20 0.36
NOTUM Q6P988 3/20 0.35
KMT2A Q03164 2/20 0.33
UCHL1 P09936 1/20 0.33
USP30 Q70CQ3 1/20 0.33
MEN1 O00255 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
CXCR1 P25024 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7375026 0.83 RAB9A (0.38) F2RNOTUMKMT2AUCHL1USP30
SCHEMBL7376845 0.77 NOTUM (0.48) NOTUMKMT2AMEN1
SCHEMBL7379131 0.74 RAB9A (0.47) NOTUMKMT2AMEN1HSD17B1HSD17B2
SCHEMBL7376902 0.73 RORC (0.38) NOTUMKMT2AMEN1
SCHEMBL7372548 0.72 RORC (0.41) NOTUMKMT2AMEN1
SCHEMBL7374152 0.71 ALDH1A1 (0.46) NOTUMKMT2AMEN1HSD17B1HSD17B2
SCHEMBL7377663 0.70 LMNA (0.32) KMT2A
SCHEMBL3141291 0.67 ALDH1A1 (0.48) NOTUMKMT2AMEN1
SCHEMBL7377289 0.67 KMT2A (0.35) KMT2A
SCHEMBL27690834 0.66 CYP2E1 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO disclosed